Edition:
United States

InspireMD Inc (NSPR.A)

NSPR.A on American Stock Exchange

0.52USD
23 Jun 2017
Change (% chg)

$0.01 (+2.18%)
Prev Close
$0.50
Open
$0.51
Day's High
$0.52
Day's Low
$0.51
Volume
2,740
Avg. Vol
32,378
52-wk High
$10.74
52-wk Low
$0.50

Latest Key Developments (Source: Significant Developments)

Inspiremd signed distribution agreements for Cguard!" EPS with Comesa GMBH
Tuesday, 13 Jun 2017 02:31pm EDT 

June 13 (Reuters) - Inspiremd Inc :Has signed distribution agreements for Cguard!" EPS with comesa GMBH.All territories previously covered by penumbra, inspiremd s former european distributor, have been transferred to local distributors.  Full Article

Inspiremd announces appointment of Paul Stuka as chairman of board
Friday, 2 Jun 2017 08:46am EDT 

June 2 (Reuters) - InspireMD Inc ::InspireMD announces appointment of Paul Stuka as chairman of the board.Says sol barer resigned from the board.Sol barer will serve as a special advisor to board.InspireMD Inc - Stuka currently serves as managing member of Osiris Partners, LLC, an investment fund, since 2000.InspireMD Inc - sol barer is stepping down from board due to conflicting professional commitments.  Full Article

InspireMD Inc Q1 revenue $569,000
Tuesday, 9 May 2017 06:19pm EDT 

May 9 (Reuters) - InspireMD Inc :Revenue for Q1 ended March 31, 2017 was $569,000 compared to $563,000 during same period in 2016.Q1 loss per share $0.81.  Full Article

Inspiremd Inc received approval to commercialize CGuard embolic prevention system
Monday, 14 Nov 2016 07:00am EST 

Inspiremd Inc :Inspiremd Inc - received regulatory approval to commercialize cguard embolic prevention system for treatment of carotid artery disease in Russia.  Full Article

InspireMD announces 1-for-25 reverse stock split
Wednesday, 28 Sep 2016 04:01pm EDT 

InspireMD Inc : Announces 1-for-25 reverse stock split .Post split, number of outstanding shares will be reduced from approximately 36 million to 1.4 million.  Full Article

Inspiremd non-GAAP net loss $0.16 per share
Tuesday, 9 Aug 2016 04:01pm EDT 

Inspiremd Inc : Revenue for q2 ended june 30, 2016 was $0.5 million compared to $0.7 million . Net loss for quarter ended june 30, 2016 was $0.19 per share . Non-Gaap net loss for quarter ended june 30, 2016 was $0.16 per share .Inspiremd reports financial results for the second quarter ended june 30, 2016.  Full Article

InspireMD amends loan & security agreement with Hercules Capital
Tuesday, 14 Jun 2016 08:00am EDT 

InspireMD Inc : InspireMD announces amendment to loan & security agreement with Hercules Capital . Announced that it has completed a restructuring of its existing debt. . Under terms of amendment, all parties have agreed to a deferral of payment of principal for a four month period beginning may 1st, 2016 .Company will be subject to certain additional covenants, and will pay a financing fee to lenders.  Full Article

InspireMD Names Dr. James Barry as President and CEO
Tuesday, 7 Jun 2016 08:00am EDT 

Inspiremd Inc : James Barry replaces Alan Milinazzo, who previously announced decision to step down as director, president and CEO in January 2016 . Prior to appointment as ceo, james barry served as inspiremd's coo since july 2014 . Barry replaces alan milinazzo . Milinazzo will continue to serve as an advisor to company. . Prior to appointment, barry served as inspiremd's chief operating officer since july 2014 .Inspiremd names dr. James barry as president and ceo.  Full Article

InspireMD's cguard highlighted at late-breaking clinical trial session
Tuesday, 17 May 2016 08:00am EDT 

Inspiremd Inc : Says Cguard Eps Reported Positive Results In Paradigm-101 .Breaking clinical trial session at the europcr 2016 conference.  Full Article

InspireMD Q1 loss per share $0.32
Tuesday, 10 May 2016 08:30am EDT 

InspireMD Inc : InspireMD reports financial results for the first quarter ended March 31, 2016 . Q1 non-GAAP loss per share $0.23 . Q1 loss per share $0.32 .Q1 revenue $600,000 versus $500,000.  Full Article

More From Around the Web